ICCM Stock Discussion
IceCure Medical Ltd. Description
Founded in 2006, Israel-based IceCure Medical develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally-invasive technology is a safe and effective alternative to hospital surgical tumor removal that is easily performed in a relatively short procedure. The system is marketed and sold worldwide, after receiving FDA and CE approvals.
Industry: Medical Care Facilities
Keywords: Medicine Clinical Medicine Tumor Breast Cancer FDA Interventional Radiology Lung Cancer Cryoablation Interventional Oncology